Celyad Oncology SA (CYAD.BR)
EUR 0.71
(-7.42%)
EUR 0.71
(-7.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 102 Thousand | - | - | 5000.00 | 6000.00 | 3.11 Million |
| Cost of Revenue | 69 Thousand | 1.44 Million | 1.52 Million | - | - | - |
| Gross Profit | 33 Thousand | -1.44 Million | -1.52 Million | 5000.00 | 6000.00 | 3.11 Million |
| Operating Expenses | 8.49 Million | 20.26 Million | 26.9 Million | 26.24 Million | 29.37 Million | 41.28 Million |
| Selling, General and Administrative Expenses | 6.25 Million | 10.33 Million | 9.66 Million | 8.99 Million | 8.72 Million | 10.38 Million |
| Research and Development Expenses | 4.66 Million | 18.92 Million | 20.77 Million | 21.59 Million | 25.23 Million | 23.57 Million |
| Other Expenses | -2.42 Million | -9 Million | -3.52 Million | -4.34 Million | -4.57 Million | 7.32 Million |
| Cost and Expenses | 8.55 Million | 20.26 Million | 26.9 Million | 26.24 Million | 29.37 Million | 41.28 Million |
| Operating Income | -8.45 Million | -40.85 Million | -26.39 Million | -26.23 Million | -29.37 Million | -38.17 Million |
| Interest Expense | 84 Thousand | 197 Thousand | 255 Thousand | 297 Thousand | 343 Thousand | 62 Thousand |
| Income Tax Expense | -191 Thousand | 65 Thousand | 10 Thousand | 297 Thousand | -8000.00 | -1.11 Million |
| Earnings before Tax | -8.51 Million | -40.87 Million | -26.5 Million | -17.2 Million | -28.64 Million | -37.42 Million |
| Net Income | -8.44 Million | -40.93 Million | -26.51 Million | -17.5 Million | -28.63 Million | -36.31 Million |
| Earnings Per Share Basic | -0.33 | -1.81 | -1.70 | -1.26 | -2.29 | -3.26 |
| Earnings Per Share Diluted | -0.33 | -1.81 | -1.70 | -1.26 | -2.29 | -3.26 |
| Weighted Average Shares Outstanding | 25.72 Million | 22.59 Million | 15.6 Million | 13.94 Million | 12.52 Million | 11.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.72 Million | 22.59 Million | 15.6 Million | 13.94 Million | 12.52 Million | 11.13 Million |
| Gross Margin | 0.32 | - | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -76.11 | - | - | -4838.40 | -4575.00 | -12.00 |
| Profit Margin | -82.82 | - | - | -3500.20 | -4772.00 | -11.66 |
| EBITDA | -7.76 Million | -39.69 Million | -25.41 Million | -15.73 Million | -27.45 Million | -36.56 Million |
| Earnings Before Tax Margin | -82.91 | - | - | -5247.80 | -4895.50 | -12.25 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 14 Thousand | 102 Thousand | 58 Thousand | 44 Thousand | - | - |
| Cost of Revenue | 9000.00 | -787 Thousand | 25 Thousand | 441 Thousand | 1.44 Million | 469 Thousand |
| Gross Profit | 5000.00 | 889 Thousand | 33 Thousand | -397 Thousand | -1.44 Million | -469 Thousand |
| Operating Expenses | 3.08 Million | 11.48 Million | 4.74 Million | 5.42 Million | 20.26 Million | 12.01 Million |
| Selling, General and Administrative Expenses | 1.73 Million | - | 2.58 Million | 3.63 Million | - | 4.19 Million |
| Research and Development Expenses | 1.53 Million | - | 2.52 Million | 1.77 Million | - | 7.89 Million |
| Other Expenses | -186 Thousand | - | -369 Thousand | -20 Thousand | -9 Million | 66 Thousand |
| Cost and Expenses | 3.09 Million | 10.69 Million | 4.77 Million | 5.86 Million | 20.26 Million | 12.48 Million |
| Operating Income | -3.08 Million | -10.59 Million | -4.71 Million | -5.82 Million | -40.85 Million | -12.48 Million |
| Interest Expense | - | 84 Thousand | 63 Thousand | 21 Thousand | 197 Thousand | 71 Thousand |
| Income Tax Expense | -34 Thousand | -191 Thousand | 63 Thousand | -106 Thousand | 65 Thousand | -68 Thousand |
| Earnings before Tax | -3.04 Million | -8.63 Million | -4.77 Million | -3.84 Million | -40.87 Million | -26.94 Million |
| Net Income | -3.04 Million | -8.44 Million | -4.7 Million | -3.74 Million | -40.93 Million | -26.87 Million |
| Earnings Per Share Basic | -0.12 | - | -0.16 | -0.17 | - | -1.19 |
| Earnings Per Share Diluted | -0.12 | - | -0.16 | -0.17 | - | -1.19 |
| Weighted Average Shares Outstanding | 25.72 Million | 25.72 Million | 28.84 Million | 22.59 Million | 22.59 Million | 22.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.72 Million | 25.72 Million | 28.84 Million | 22.59 Million | 22.59 Million | 22.59 Million |
| Gross Margin | 0.36 | 8.72 | 0.57 | -9.02 | - | - |
| EBIT Margin | -203.93 | - | -77.03 | -123.34 | - | - |
| Profit Margin | -217.43 | -82.82 | -81.17 | -85.00 | - | - |
| EBITDA | -2.85 Million | - | -4.46 Million | -5.42 Million | - | -12.01 Million |
| Earnings Before Tax Margin | -220.21 | -103.89 | -81.24 | -132.36 | - | - |
300008
SITC-PA
TANFACIND
BDCM
FBGI
VILN